UB Paderborn / Katalog / Suche / in CDI

Development of the adverse outcome pathway "alkylation of DNA in male premeiotic germ cells leading to heritable mutations" using the OECD's users' handbook supplement

Environmental and molecular mutagenesis, 2015-12, Vol.56 (9), p.724-750

2015

Link zum Volltext

Verfügbarkeit prüfen

Adverse outcome pathways: Application to enhance mechanistic understanding of neurotoxicity

Pharmacology & therapeutics (Oxford), 2017-11, Vol.179, p.84-95

2017

Link zum Volltext

Verfügbarkeit prüfen

Towards a qAOP framework for predictive toxicology - Linking data to decisions

Computational toxicology, 2022-02, Vol.21, p.100195-100195, Article 100195

2022

Link zum Volltext

Verfügbarkeit prüfen

Using mode of action information to improve regulatory decision-making: An ECETOC/ILSI RF/HESI workshop overview

Critical reviews in toxicology, 2011-03, Vol.41 (3), p.175-186

2011

Link zum Volltext

Verfügbarkeit prüfen

Case study illustrating the WHO IPCS guidance on characterization and application of physiologically based pharmacokinetic models in risk assessment

Regulatory toxicology and pharmacology, 2013-06, Vol.66 (1), p.116-129

2013

Link zum Volltext

Verfügbarkeit prüfen

Procedural application of mode-of-action and human relevance analysis: styrene-induced lung tumors in mice

Critical reviews in toxicology, 2024-02, Vol.54 (2), p.134-151

2024

Link zum Volltext

Verfügbarkeit prüfen

New developments in the evolution and application of the WHO/IPCS framework on mode of action/species concordance analysis

Journal of applied toxicology, 2014-01, Vol.34 (1), p.1-18

2014

Link zum Volltext

Verfügbarkeit prüfen

Developing and applying the adverse outcome pathway concept for understanding and predicting neurotoxicity

Neurotoxicology (Park Forest South), 2017-03, Vol.59, p.240-255

2017

Link zum Volltext

Verfügbarkeit prüfen

Engaging Expert Peers in the Development of Risk Assessments

Risk analysis, 2007-12, Vol.27 (6), p.1609-1621

2007

Link zum Volltext

Verfügbarkeit prüfen

Evolution of mode of action/adverse outcome pathway analyses

Toxicology letters, 2014-09, Vol.229, p.S10-S10

Meek, M.E. (Bette)

2014

Link zum Volltext

Verfügbarkeit prüfen

A user-friendly tool to assess combined exposures to indoor air pollutants in public spaces of children

Food and chemical toxicology, 2022-07, Vol.165, p.113141, Article 113141

2022

Link zum Volltext

Verfügbarkeit prüfen

Evolution of chemical-specific adjustment factors (CSAF) based on recent international experience; increasing utility and facilitating regulatory acceptance

Critical reviews in toxicology, 2017-10, Vol.47 (9), p.733-753

2017

Link zum Volltext

Verfügbarkeit prüfen

Gaining acceptance for the use of in vitro toxicity assays and QIVIVE in regulatory risk assessment

Toxicology (Amsterdam), 2015-06, Vol.332, p.112-123

2015

Link zum Volltext

Verfügbarkeit prüfen

Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling

Regulatory toxicology and pharmacology, 2003-12, Vol.38 (3), p.345-367

2003

Link zum Volltext

Verfügbarkeit prüfen

International experience in addressing combined exposures: Increasing the efficiency of assessment

Toxicology (Amsterdam), 2013-11, Vol.313 (2-3), p.185-189

Meek, M.E. (Bette)

2013

Link zum Volltext

Verfügbarkeit prüfen

AOPs in hazard characterization for human health

Current opinion in toxicology, 2017-04, Vol.3, p.80-86

Meek, M.E. (Bette)

2017

Link zum Volltext

Verfügbarkeit prüfen

Problem Formulation for EFSA Scientific Assessments

EFSA supporting publications, 2022-07, Vol.19 (7), p.n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Recent developments in frameworks to consider human relevance of hypothesized modes of action for tumours in animals

Environmental and molecular mutagenesis, 2008-03, Vol.49 (2), p.110-116

Meek, M.E. Bette

2008

Link zum Volltext

Verfügbarkeit prüfen

Proposed mode of action of benzene-induced leukemia: Interpreting available data and identifying critical data gaps for risk assessment

Chemico-biological interactions, 2010-03, Vol.184 (1), p.279-285

2010

Link zum Volltext

Verfügbarkeit prüfen

Development of the adverse outcome pathway “alkylation of DNA in male premeiotic germ cells leading to heritable mutations” using the OECD 's users' handbook supplement

Environmental and molecular mutagenesis, 2015-12, Vol.56 (9), p.724-750

2015

Link zum Volltext

Verfügbarkeit prüfen

Qualitative Methods for Characterizing Uncertainty in Exposure Assessment

Toxicology letters, 2008-10, Vol.180, p.S4-S4

2008

Link zum Volltext

Verfügbarkeit prüfen

A framework for fit-for-purpose dose response assessment

Regulatory toxicology and pharmacology, 2013-07, Vol.66 (2), p.234-240

2013

Link zum Volltext

Verfügbarkeit prüfen

Tools for the prioritization of substances on the Domestic Substances List in Canada on the basis of hazard

Regulatory toxicology and pharmacology, 2009-12, Vol.55 (3), p.382-393

2009

Link zum Volltext

Verfügbarkeit prüfen

Preface

Journal of Toxicology and Environmental Health, Part A, 2010-01, Vol.73 (2-3), p.93-95

2010

Link zum Volltext

Verfügbarkeit prüfen

Preface

Journal of Toxicology and Environmental Health, Part A: Health Risk Assessment of Essential Metals, 2010-01, Vol.73 (2-3), p.93-95

2010

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Development of the adverse outcome pathway "alkylation of DNA in male premeiotic germ cells leading to heritable mutations" using the OECD's users' handbook supplement

Adverse outcome pathways: Application to enhance mechanistic understanding of neurotoxicity

Towards a qAOP framework for predictive toxicology - Linking data to decisions

Using mode of action information to improve regulatory decision-making: An ECETOC/ILSI RF/HESI workshop overview

Case study illustrating the WHO IPCS guidance on characterization and application of physiologically based pharmacokinetic models in risk assessment

Procedural application of mode-of-action and human relevance analysis: styrene-induced lung tumors in mice

New developments in the evolution and application of the WHO/IPCS framework on mode of action/species concordance analysis

Developing and applying the adverse outcome pathway concept for understanding and predicting neurotoxicity

Engaging Expert Peers in the Development of Risk Assessments

Evolution of mode of action/adverse outcome pathway analyses

A user-friendly tool to assess combined exposures to indoor air pollutants in public spaces of children

Evolution of chemical-specific adjustment factors (CSAF) based on recent international experience; increasing utility and facilitating regulatory acceptance

Gaining acceptance for the use of in vitro toxicity assays and QIVIVE in regulatory risk assessment

Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling

International experience in addressing combined exposures: Increasing the efficiency of assessment

AOPs in hazard characterization for human health

Problem Formulation for EFSA Scientific Assessments

Recent developments in frameworks to consider human relevance of hypothesized modes of action for tumours in animals

Proposed mode of action of benzene-induced leukemia: Interpreting available data and identifying critical data gaps for risk assessment

Development of the adverse outcome pathway “alkylation of DNA in male premeiotic germ cells leading to heritable mutations” using the OECD 's users' handbook supplement

Qualitative Methods for Characterizing Uncertainty in Exposure Assessment

A framework for fit-for-purpose dose response assessment

Tools for the prioritization of substances on the Domestic Substances List in Canada on the basis of hazard

Preface

Preface

Suchergebnisse filtern